{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:41:41Z","timestamp":1770752501266,"version":"3.50.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ejmg.2023.104706","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T11:33:02Z","timestamp":1674041582000},"page":"104706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ryanodine receptor 1 related myasthenia like myopathy responsive to pyridostigmine"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8343-3084","authenticated-orcid":false,"given":"Emilie Boye","family":"Lester","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin Jakob","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lone Walentin","family":"Laulund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"Illum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Dunkhase-Heinl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik Daa","family":"Schr\u00f8der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5206-4327","authenticated-orcid":false,"given":"Christina Ringmann","family":"Fagerberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejmg.2023.104706_bib1","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ana.22510","article-title":"Prevalence of congenital myopathies in a representative pediatric United States population","volume":"70","author":"Amburgey","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejmg.2023.104706_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1750-1172-8-117","article-title":"Genotype-phenotype correlations in recessive RYR1-related myopathies","volume":"8","author":"Amburgey","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"issue":"6","key":"10.1016\/j.ejmg.2023.104706_bib3","first-page":"852","article-title":"Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse models","volume":"5","author":"Dowling","year":"2012","journal-title":"Dis. Model. Mech."},{"issue":"4","key":"10.1016\/j.ejmg.2023.104706_bib4","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/ajmg.a.38418","article-title":"Treating pediatric neuromuscular disorders the future is now","volume":"176","author":"Dowling","year":"2018","journal-title":"Am. J. Med. Genet."},{"issue":"4","key":"10.1016\/j.ejmg.2023.104706_bib5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1474-4422(14)70201-7","article-title":"Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment","volume":"14","author":"Engel","year":"2015","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.ejmg.2023.104706_bib6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00109-013-0994-4","article-title":"Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy","volume":"91","author":"Gibbs","year":"2013","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ejmg.2023.104706_bib7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/B978-0-444-64076-5.00036-3","article-title":"The genetics of congenital myopathies","volume":"148","author":"Gonorazky","year":"2018","journal-title":"Handb. Clin. Neurol."},{"issue":"8","key":"10.1016\/j.ejmg.2023.104706_bib8","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.nmd.2014.05.003","article-title":"RYR1-related congenital myopathy with fatigable weakness, responding to pyridostigimine","volume":"24","author":"Illingworth","year":"2014","journal-title":"Neuromuscul. Disord."},{"issue":"3","key":"10.1016\/j.ejmg.2023.104706_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrneurol.2017.191","article-title":"Congenital myopathies: disorders of excitation-contraction coupling and muscle contraction","volume":"14","author":"Jungbluth","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.ejmg.2023.104706_bib10","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/humu.22056","article-title":"Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene-associated myopathies","volume":"33","author":"Klein","year":"2012","journal-title":"Hum. Mutat."},{"issue":"11","key":"10.1016\/j.ejmg.2023.104706_bib11","doi-asserted-by":"crossref","first-page":"a003996","DOI":"10.1101\/cshperspect.a003996","article-title":"Ryanodine receptors: structure, expression, molecular details, and function in calcium release","volume":"2","author":"Lanner","year":"2010","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"1","key":"10.1016\/j.ejmg.2023.104706_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13395-020-00243-4","article-title":"Ryanodine receptor 1-related disorders: an historical perspective and proposal for a unified nomenclature","volume":"10","author":"Lawal","year":"2020","journal-title":"Skeletal Muscle"},{"issue":"4","key":"10.1016\/j.ejmg.2023.104706_bib13","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3233\/JND-200549","article-title":"Ryanodine receptor 1-related myopathies: quantification of intramuscular fatty infiltration from T1-weighted MRI","volume":"8","author":"Lawal","year":"2021","journal-title":"J. Neuromuscul. Dis."},{"issue":"10","key":"10.1016\/j.ejmg.2023.104706_bib14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/11593300-000000000-00000","article-title":"Treatment of myasthenia gravis focus on pyridostigmine","volume":"31","author":"Maggi","year":"2011","journal-title":"Clin. Drug Invest."},{"issue":"6","key":"10.1016\/j.ejmg.2023.104706_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/cells10061521","article-title":"Ion Channel gene mutations causing skeletal muscle disorders: pathomechanisms and opportunities for therapy","volume":"10","author":"Maggi","year":"2021","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.ejmg.2023.104706_bib16","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1212\/WNL.0000000000004894","article-title":"Atypical periodic paralysis and myalgia: a novel RYR1 phenotype","volume":"90","author":"Matthews","year":"2018","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ejmg.2023.104706_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.nmd.2013.11.003","article-title":"Approach to the diagnosis of congenital myopathies","volume":"24","author":"North","year":"2014","journal-title":"Neuromuscul. Disord."},{"issue":"3","key":"10.1016\/j.ejmg.2023.104706_bib18","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00000542-200503000-00007","article-title":"Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the north american population","volume":"102","author":"Sambuughin","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejmg.2023.104706_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0404.2006.00608.x","article-title":"Titin and ryanodine receptor antibodies in myasthenia gravis","volume":"113","author":"Skeie","year":"2006","journal-title":"Acta Neurol. Scand."},{"issue":"1","key":"10.1016\/j.ejmg.2023.104706_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jocn.2011.05.010","article-title":"A study of a family with the skeletal muscle RYR1 mutation (c.7354C>T) associated with central core myopathy and malignant hyperthermia susceptibility","volume":"19","author":"Taylor","year":"2012","journal-title":"J. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.ejmg.2023.104706_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s40478-016-0392-6","article-title":"Review of RyR1 pathway and associated pathomechanisms","volume":"4","author":"Witherspoon","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"issue":"18","key":"10.1016\/j.ejmg.2023.104706_bib23","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1093\/hmg\/ddl221","article-title":"Characterization of recessive RYR1 mutations in core myopathies","volume":"15","author":"Zhou","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.ejmg.2023.104706_bib24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.nmd.2009.12.005","article-title":"Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene","volume":"20","author":"Zhou","year":"2010","journal-title":"Neuromuscul. Disord."},{"issue":"7","key":"10.1016\/j.ejmg.2023.104706_bib25","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/humu.22326","article-title":"RyR1 deficiency in congenital myopathies disrupts excitation-contraction coupling","volume":"34","author":"Zhou","year":"2013","journal-title":"Hum. Mutat."}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721223000125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721223000125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:53:43Z","timestamp":1761710023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721223000125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1769721223000125"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2023.104706","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ryanodine receptor 1 related myasthenia like myopathy responsive to pyridostigmine","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2023.104706","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104706"}}